Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana

Pediatric Infectious Disease Journal

Volumn 33, Issue 11, 2014, Pages 1141-1147

  Powis, Kathleen ^a,b,c   Lockman, Shahin ^b,c,d   Smeaton, Laura ^e   Hughes, Michael D ^e   Fawzi, Wafaie ^b   Ogwu, Anthony ^c   Moyo, Sikhulile ^c   Van Widenfelt, Erik ^c   Von Oettingen, Julia ^f   Makhema, Joseph ^c   Essex, Max ^b,c   Shapiro, Roger L ^g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Growth; Hiv exposed uninfected infants; Maternal vitamin D; Morbidity; Mortality

Indexed keywords

25 HYDROXYVITAMIN D; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA; VITAMIN D;

ANTIVIRAL THERAPY; ARTICLE; BOTSWANA; CASE CONTROL STUDY; CHILD GROWTH; CONTROLLED STUDY; DELIVERY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; MAJOR CLINICAL STUDY; MATERNAL PLASMA; NEWBORN MORBIDITY; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; BIRTH; BLOOD; CD4 LYMPHOCYTE COUNT; CHILD DEVELOPMENT; COMPLICATION; DEVELOPMENTAL DISABILITIES; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INFANT; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEASON; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ANTI-HIV AGENTS; BOTSWANA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD DEVELOPMENT; DEVELOPMENTAL DISABILITIES; FEMALE; HIV; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFANT MORTALITY; MALE; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; SEASONS; SEX FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84926103643     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000428     Document Type: Article

References (38)

1. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282-2294.
2. Marazzi MC, Nielsen-Saines K, Buonomo E, et al. Increased infant human immunodeficiency virus-type one free survival at one year of age in Sub-Saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Pediatr Infect Dis J. 2009;28:483-487.
3. De Vincenzi I; Kesho Bora Study Group. Triple-antiretroviral (ARV) prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1 (MTCT): The Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. In: 5th IAS Conference on HIV Pathogenesis and Treatment. Cape Town, South Africa; 2009. Abstract # LBPECO1.
4. Chasela CS, Hudgens MG, Jamieson DJ, et al; BAN Study Group. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362:2271-2281.
5. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr. 2006;41:504-508.
6. Marinda E, Humphrey JH, Iliff PJ, et al; ZVITAMBO Study Group. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26:519-526.
7. Shapiro RL, Lockman S, Kim S, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breastfeeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis. 2007;196:562-569.
8. Muhangi L, Lule SA, Mpairwe H, et al. Maternal HIV infection and other factors associated with growth outcomes in HIV-uninfected infants in Entebe, Uganda. Public Health Nutr. 2013;16:1548-1557.
9. Moraleda C, de Deus N, Serna-Bolea C, et al. Impact of HIV-exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in Sub-Saharan Africa. JAIDS. 2014;65:182-189.
10. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80(suppl):1717S-1720S.
11. Boonstra A, Barrat FJ, Crain C, et al. 1α,25-Dihydroxyvitamin D has a direct effect on naïve CD4+ T cells to enhance the development of Th2 cells. J Immunol. 2001;167:4974-4980.
12. Bar-Shavit Z, Noff D, Edelstein S, et al. 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int. 1981;33:673-676.
13. Mariani E, Ravaglia G, Forti P, et al. Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol. 1999;116:19-27.
14. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-1773.
15. Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis. 2009;200:1022-1030.
16. Bodnar LM, Simhan HN, Powers RW, et al. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137:447-452.
17. Holick MF. Vitamin D deficiency. New Engl J Med. 2007;357:266-281.
18. Finkelstein JL, Mehta S, Duggan C, et al. Maternal vitamin D status and child morbidity, anemia, and growth in human immunodeficiency virusexposed children in Tanzania. Pediatr Infect Dis J. 2012;31:171-175.
19. Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother. 2012;67:2222-2230.
20. Cervero M, Agud JL, Gracia-Lacalle C, et al. Prevalence of Vitamin D deficiency and its related risk factors in a Spanish Cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2012;28:963-971.
21. World Health Organization. Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/. Accessed March 10, 2014.
22. Salle BL, Delvin EE, Lapillonne A, et al. Perinatal metabolism of vitamin D. Am J Clin Nutr. 2000;71(suppl):S1317-1324.
23. World Health Organization. World Health Organization Child Growth Standards. Available at: http://www.who.int/childgrowth/1-what.pdf. Accessed December 18, 2009.
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
25. Amukele TK, Soko D, Katundu P, et al. Vitamin D levels in Malawian infants from birth to 24 months. Arch Dis Child. 2013;98:180-183.
26. Lockman S, Smeaton L, Shapiro R, et al. Morbidity and mortality among infants born to HIV-infected mothers and randomized to breastfeeding versus formula-feeding in Botswana (Mashi Study). In: XVI International AIDS Conference, Toronto, Canada; 2006. Abstract # TUPE0357.
27. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440-1451.
28. Maxwell CS, Carbone ET, Wood RJ. Better newborn vitamin D status lowers RSV-associated bronchiolitis in infants. Nutr Rev. 2012;70:548-552.
29. Mohamed WA, Al-Shehri MA. Cord blood 25-hydroxyvitamin D levels and the risk of acute lower respiratory tract infection in early childhood. J Trop Pediatr. 2013;59:29-35.
30. Nnyepi MS, Mmopelwa D, Codjia P, et al. Child Nutrition Situation in Botswana: Observations From the 2000 and 2007 Household Surveys. New York, NY: UNICEF; 2011.
31. Black RE, Victora CG, Walker S P, et al. Matnerna and Child Nutrition 1: maternal and child undernutirition and overweight in low-income and middle income countries. Lancet 2013:382:427-51.
32. Gordon NH, Halileh S. An analysis of cross sectional survey data of stunting among Palestinian children less than five years of age. Matern Child Health J. 2013;17:1288-1296.
33. Ikeda N, Irie Y, Shibuya K. Determinants of reduced stunting in Cambodia: analysis of pooled data from Demographic Health Surveys. Bull World Health Organ 2013;91:341-349.
34. Pelletier DL, Frongillo EA Jr, Schroeder DG, et al. The effects of malnutrition on child mortality in developing countries. Bull World Health Organ. 1995;73:443-448.
35. Caulfield LE, de Onis M, Blössner M, et al. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004;80:193-198.
36. Olofin I, McDonald CM, Ezzati M, et al. Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: pooled analysis of ten prospective studies. PLoS One 8: e64636.
37. Walker S P, Wachs TD, Grantham-McGregor S, et al. Inequality in early childhood: risk and protective factors for early child development. Lancet. 2011;378:1325-1338.
38. Grantham-McGregor S, Cheung YB, Cueto S, et al; International Child Development Steering Group. Developmental potential in the first 5 years for children in developing countries. Lancet. 2007;369:60-70.